Having identified the prevalence and increased risk of masked hypertension in pregnant women, a recent study suggests that an office blood pressure (BP) of at least 125/75 mm Hg in the second half of gestation may be appropriate to indicate out-of-office measurements in high-risk pregnancies.
An association seems to exist between an elevated blood pressure (BP) and a decrease in cognitive scores among functioning older adults, according to a recent study. Conversely, an elevated BP is associated with modest improvements in cognitive function among poorly functioning elders.
Exercise training, when combined with ranolazine treatment, improves angina threshold, oxygen pulse and peak oxygen consumption in patients with chronic stable angina pectoris, a recent study has found.
Poor adherence to blood pressure-lowering medications does not appear to be a cause of masked uncontrolled hypertension (MUCH), with a recent study showing that the levels of medication adherence is similar between patients with MUCH and those with true controlled hypertension.
In patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) with concomitant congestive heart failure (CHF), an early invasive strategy reduces the likelihood of poor outcomes, a recent study has shown.
In heart failure patients with reduced ejection fraction (HFrEF) and renal impairment or hypotension, sacubitril/valsartan has been shown to be an effective angiotensin receptor and neprilysin inhibition (ARNI) intervention, reports a recent study.
Treatment with nebivolol yields more favourable changes in 24-hour, intradialytic and daytime systolic and diastolic blood pressure variability in patients with intradialytic hypertension, a study has found.
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
Adding a third drug to achieve the target blood pressure (BP) seems to be more effective than increasing the dose of existing dual therapy without any increase in adverse events, suggest the results of a meta-analysis, adding that early use of triple therapy can help improve hypertension control.